Fred Hutch News Service

Fred Hutch News Service

At Fred Hutch, our diverse teams of leading scientists and dedicated humanitarians collaborate to tackle cancer, HIV/AIDS, and other health challenges. Among our researchers are three Nobel Prize winners, all driven by an unwavering commitment to advancing health knowledge and spreading hope globally. Our collective efforts focus on finding innovative methods for early cancer detection, when treatment success is greatest; creating effective therapies with reduced side effects; and exploring strategies to prevent cancer development altogether.

Trade/B2B
English
Research Company/Group

Outlet metrics

Domain Authority
78
Ranking

Global

#128020

United States

#32730

Health/Health Conditions and Concerns

#67

Traffic sources
Monthly visitors

Articles

  • 4 weeks ago | fredhutch.org | Sabrina Richards

    After receiving his PhD in biostatistics at the University of Washington, Gilbert moved to Zelen’s department at Harvard, focusing on analyzing and designing clinical trials to test treatments for HIV. From the beginning, he integrated students into his research, a theme that would continue throughout his career. In 2001, Gilbert’s doctoral mentor, UW biostatistician Steven Self, PhD, enticed him back to Seattle to support the rapidly expanding statistical science developments at Fred Hutch.

  • 1 month ago | fredhutch.org | John Higgins

    Small cell lung cancer, or SCLC, is aggressive, lethal and particularly cruel because chemotherapy initially works so well. But within just a few months, SCLC becomes resistant to drugs and dashes hopes. “What is seen in the clinic is often quite remarkable responses to chemotherapy initially, but these are just transient responses and tumors come back,” said David MacPherson, PhD, a Fred Hutch Cancer Center scientist who specializes in small cell lung cancer.

  • 1 month ago | fredhutch.org | Bonnie Rochman

    In 2023, Jack David was on his family’s annual trip to Priest Lake, Idaho, when he woke up in the middle of that vacation and felt a swollen lymph node. He made a few jokes about what it could be, then saw his doctor when he returned home to Seattle, which led to a referral to an otolaryngologist. David, 49, was given a prescription for antibiotics, but the node didn’t subside. Results from a biopsy appeared normal, but the node still didn’t disappear.

  • 1 month ago | fredhutch.org | Sabrina Richards

    Bradley and Abdel-Wahab have a long-standing collaboration working out how mutations in certain splicing factor genes drive leukemia, with an eye toward leveraging the knowledge to develop new treatments. “We were wondering, could cancers with mutations in the splicing machineries just on their own generate novel proteins that could be really amazing therapeutic targets — if we could figure out what those novel proteins are and what the immune cells that recognize them are,” Abdel-Wahab said.

  • 1 month ago | fredhutch.org | John Higgins

    From the earliest days of the pandemic that shocked the world in 2020, researchers at Fred Hutch Cancer Center tracked the rapid evolution and spread of the virus that causes COVID-19 by studying how its genomic sequence — the order of its genetic building blocks — changed over time.

Fred Hutch News Service journalists